BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 20565478)

  • 1. Real-time, once-daily monitoring of symptoms and FEV in cystic fibrosis patients--a feasibility study using a novel device.
    Sarfaraz S; Sund Z; Jarad N
    Clin Respir J; 2010 Apr; 4(2):74-82. PubMed ID: 20565480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report.
    Scott AI; Clarke BE; Healy H; D Emden M; Bell SC
    JOP; 2000 Nov; 1(4):208-10. PubMed ID: 11856863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
    Rosenstein BJ; Hall DE
    Johns Hopkins Med J; 1980 Nov; 147(5):188-9. PubMed ID: 7441939
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
    J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations between the frequency of the DeltaF 508 mutation and the course of pulmonary disease in cystic fibrosis patients infected with Pseudomonas aeruginosa.
    Rosenecker J
    Eur J Med Res; 2000 Aug; 5(8):356-9. PubMed ID: 10958769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on treatment of pulmonary exacerbations in cystic fibrosis.
    Smyth A
    Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchopulmonary infections in mucoviscidosis].
    Hein J; Wiersbitzky S; Wunderlich P
    Z Erkr Atmungsorgane; 1988; 170(2):201-11. PubMed ID: 3135674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting acute pulmonary exacerbations in cystic fibrosis--evolving concepts.
    Selvadurai H
    Clin Respir J; 2010 Apr; 4(2):65-6. PubMed ID: 20565478
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.